Inhibition of STAT3 by Anticancer Drug BendamustineKazunori Iwamoto, Akira Asai|PLoS ONE|2017Cited by 16
Discovery of a New STAT3 Inhibitor Acting on the Linker DomainTatsuya Koseki, Akira Asai|Biological and Pharmaceutical Bulletin|2019Cited by 13
Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell linesKeisuke Taniguchi, Akira Asai|Scientific Reports|2021Cited by 12
Visualization and quantification of dynamic STAT3 homodimerization in living cells using homoFluoppiYusuke Okada, Akira Asai|Scientific Reports|2018Cited by 11
Tributylhexadecylphosphonium Bromide, a Novel Nuclear Factor of Activated T Cells Signaling Inhibitor, Blocks Interleukin-2 Induction Associated with Inhibition of p70 Ribosomal Protein S6 Kinase PhosphorylationHiroshi Umehara, Akira Asai|Biological and Pharmaceutical Bulletin|2012Cited by 4